Consolidated Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Oct. 27, 2023	Oct. 28, 2022	Oct. 27, 2023	Oct. 28, 2022
Income Statement [Abstract]
Net sales	$ 7,984	$ 7,585	$ 15,686	$ 14,955
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets	2,761	2,535	5,390	5,051
Research and development expense	698	676	1,365	1,368
Selling, general, and administrative expense	2,686	2,617	5,299	5,184
Amortization of intangible assets	425	421	855	844
Restructuring charges, net	40	30	94	44
Certain litigation charges	65	0	105	0
Other operating income, net	(31)	(97)	(30)	(62)
Operating profit	1,340	1,404	2,608	2,528
Other non-operating income, net	(154)	(109)	(230)	(192)
Interest expense, net	180	118	329	282
Income before income taxes	1,313	1,395	2,510	2,438
Income tax provision	402	959	802	1,072
Net income	911	435	1,708	1,367
Net income attributable to noncontrolling interests	(2)	(8)	(8)	(10)
Net income attributable to Medtronic	$ 909	$ 427	$ 1,700	$ 1,356
Basic earnings per share (usd per share)	$ 0.68	$ 0.32	$ 1.28	$ 1.02
Diluted earnings per share (usd per share)	$ 0.68	$ 0.32	$ 1.28	$ 1.02
Basic weighted average shares outstanding (shares)	1,330.2	1,329.4	1,330.3	1,329.4
Diluted weighted average shares outstanding (shares)	1,331.9	1,332.0	1,332.8	1,333.3